WallStreetZenWallStreetZen

NASDAQ: PRQR
Proqr Therapeutics Nv Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PRQR past revenue growth

How has PRQR's revenue growth performed historically?
Company
128.23%
Industry
145.73%
Market
17.2%
PRQR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PRQR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PRQR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PRQR earnings and revenue history

Current Revenue
$10.6M
Current Earnings
-$31.2M
Current Profit Margin
-295.2%

PRQR Return on Equity

Current Company
-56.7%
Current Industry
-63.5%
Current Market
188%
PRQR's Return on Equity (-56.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PRQR announces earnings.

PRQR Return on Assets

Current Company
-19.2%
Current Industry
2.9%
PRQR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PRQR Return on Capital Employed

Current Company
-25.79%
Current Industry
19.5%
PRQR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PRQR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PRQR$10.35M-$26.33M-$30.56M+9.83%N/A
GLSI$0.00-$8.89M-$8.89MN/AN/A
OBIO$2.76M-$48.20M-$49.12M-80.21%N/A
AEON$0.00$24.09M$24.05MN/AN/A
ZURA$0.00-$60.36M-$69.24MN/AN/A
View Top Biotech Stocks

PRQR earnings dates

Next earnings date
May 14, 2024

Proqr Therapeutics Nv Earnings & Revenue FAQ

What were PRQR's earnings last quarter?

On Invalid Date, Proqr Therapeutics Nv (NASDAQ: PRQR) reported Q4 2023 earnings per share (EPS) of -$0.08, up 59.16% year over year. Total Proqr Therapeutics Nv earnings for the quarter were -$6.09 million. In the same quarter last year, Proqr Therapeutics Nv's earnings per share (EPS) was -$0.19.

If you're new to stock investing, here's how to buy Proqr Therapeutics Nv stock.

What was PRQR's earnings growth in the past year?

As of Q2 2024, Proqr Therapeutics Nv's earnings has grown year over year. Proqr Therapeutics Nv's earnings in the past year totalled -$30.56 million.

What is PRQR's earnings date?

Proqr Therapeutics Nv's earnings date is Invalid Date. Add PRQR to your watchlist to be reminded of PRQR's next earnings announcement.

What was PRQR's revenue last quarter?

On Invalid Date, Proqr Therapeutics Nv (NASDAQ: PRQR) reported Q4 2023 revenue of $6.91 million up 436.02% year over year. In the same quarter last year, Proqr Therapeutics Nv's revenue was $1.29 million.

What was PRQR's revenue growth in the past year?

As of Q2 2024, Proqr Therapeutics Nv's revenue has grown 128.23% year over year. This is 17.51 percentage points lower than the US Biotechnology industry revenue growth rate of 145.73%. Proqr Therapeutics Nv's revenue in the past year totalled $10.35 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.